DoD Melanoma, Translational Research Award
The summary for the DoD Melanoma, Translational Research Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DoD Melanoma, Translational Research Award: The FY19 MRP Translational Research Award supports hypothesis-driven, translational, high-impact research. The Translational Research Award mechanism encourages applications with mature research projects that specifically focus on critical scientific or clinical melanoma issues, which, if successfully addressed, have the potential to make a major impact. Important factors under consideration will be continuity of research, clinical applicability, and leveraging of clinical samples from clinical trials and/or biorepositories. The Translational Research Award supports identifying scientific outcomes, through rigorous, robust research, that are translatable toward treatment and/or preventive strategies. Research proposed should aim to accelerate promising findings toward clinical applicability and leverage research results to maximize impact. Proposed studies should focus on the commonalities in melanoma research to advance the understanding of the field The Translational Research Award is not intended to study research into established late-stage disease models, clinical utility of PD-1 in combination with other therapeutics, or established cell lines. The MRP is not requesting research into established macrometastatic disease, models of metastatic disease using established cell lines, or treatment of macrometastatic disease. Studies involving non-melanoma skin cancers are not allowed under the FY19 MRP.
Federal Grant Title: | DoD Melanoma, Translational Research Award |
Federal Agency Name: | Dept of the Army USAMRAA (DOD-AMRAA) |
Grant Categories: | Science and Technology |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | W81XWH-19-MRP-TRA |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 12.420 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | October 23rd, 2019 |
Original Application Deadline: | October 23rd, 2019 |
Posted Date: | May 16th, 2019 |
Creation Date: | May 16th, 2019 |
Archive Date: | November 22nd, 2019 |
Total Program Funding: | $1,920,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 2 |
Cost Sharing or Matching: | No |
Last Updated: | May 16th, 2019 |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- CDMRP Help Desk
Phone: 301-682-5507
Email: [email protected]
CDMRP Help Desk - Similar Government Grants
- • DoD Tick-Borne Disease, Idea Development Award
- • DoD Tick-Borne Disease, Therapeutic/Diagnostic Research Award
- • DoD Rare Cancers, Concept Award
- • DoD Multiple Sclerosis, Early Investigator Research Award
- • DoD Rare Cancers, Idea Development Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- More Grants from the Dept of the Army USAMRAA
- • DoD Tick-Borne Disease, Idea Development Award
- • DoD Tick-Borne Disease, Therapeutic/Diagnostic Research Award
- • DoD Rare Cancers, Concept Award